1.
Tocilizumab in Severe and Critical COVID-19 Pneumonia: Streamlining the Mixed Signals. Acta Med Philipp [Internet]. 2024 Apr. 15 [cited 2025 Oct. 3];58(6). Available from: https://luna.upm.edu.ph/index.php/acta/article/view/10156